RXSTNasdaqOphthalmic GoodsFiscal year ends December 31

RxSight, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026

$4.69+0.18 (+3.99%)

Close on Oct 19, 2026

Market cap: $194.59M
P/E (TTM): –
Dividend yield: –

RxSight, Inc. balance sheet

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31
Cash & Equivalents	20	17	10	13	25	14	8.83
Short-Term Investments	208	221	117	94	135	55	–
Cash & Short-Term Investments	228	237	127	106	159	69	8.83
Receivables	23	30	20	11	4.86	2.87	–
Inventory	32	22	17	15	8.03	8.29	–
Prepaid Expenses & Other	4.39	4.54	3.52	2.96	4.07	1.37	–
Total Current Assets	287	294	168	135	176	82	–
Property, Plant & Equipment	13	12	11	10	11	13	–
Gross Property, Plant & Equipment	40	38	34	30	28	26	–
Accumulated Depreciation	-27	-25	-23	-20	-16	-12	–
Operating Lease Right-of-Use Assets	9.96	11	2.44	3.94	4.28	5.32	–
Other Long-Term Assets	0.59	0.36	0.15	0.77	0.11	0.11	–
Total Assets	312	319	183	150	193	101	–
Accounts Payable	5.30	4.54	3.86	2.60	1.69	1.13	–
Accrued Expenses	20	20	15	13	7.86	4.17	–
Current Portion of Leases	1.13	0.95	1.76	1.82	1.51	1.25	–
Deferred Revenue (Current)	3.26	3.11	2.05	1.35	0.62	0.42	–
Total Current Liabilities	26	26	21	17	11	12	–
Long-Term Leases	9.81	11	1.09	2.81	3.63	5.04	–
Operating Lease Liabilities	11	12	2.86	4.63	5.13	6.29	–
Total Liabilities	36	37	22	60	54	45	–
Preferred Stock	0	0	0	0	0	0	–
Common Stock	0.04	0.04	0.04	0.03	0.03	0	–
Additional Paid-In Capital	937	903	755	636	618	0	–
Retained Earnings	-661	-622	-595	-546	-479	-431	–
Comprehensive Income & Other	0.05	0.17	-0.01	-0.10	-0.02	0.00	–
Shareholders' Equity	276	281	160	90	138	-431	–
Total Equity	276	281	160	90	138	-431	-420
Total Liabilities & Equity	312	319	183	150	193	101	–
Shares Outstanding(shares)	41	40	36	28	27	–	–
Allowance for Credit Losses	0	0	0	0	0	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 77.5%
Operating margin: -43.2%
Net margin: -36.8%
Return on equity, FY2025: -14.0%

Financial strength

Current ratio: 4.07
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 16.6%

Valuation

P/E ratio: –
Price to sales: 1.53
Price to book: 0.74
Dividend yield: –